Singpass is undergoing maintenance on 12 Dec 2021, from 12am to 6am (Singapore time). You will not be able to use your Singpass ID and password to login. You may still use Singpass Mobile QR to login to our digital services. We apologise for any inconvenience caused.

my cpf

View personal CPF information and transactions for retirement, home ownership, healthcare, and more.


CPF overview

CPF empowers you to secure your life goals. Save for retirement, home ownership, and healthcare protection.

Growing your savings

For greater peace of mind in your golden years, CPF provides you with a strong foundation for retirement by helping you save for your retirement income, home ownership and healthcare needs.

Retirement income

Build a strong foundation for your retirement and get more from what you save in your golden years.

Home ownership

Owning a home can be affordable. Take care of your mortgage repayment, while protecting your retirement nest egg.

Healthcare financing

Learn how CPF can give you peace of mind to manage your basic healthcare sum and meet the costs of your healthcare needs.

Account services

Throughout your working life and in retirement, you can easily access your CPF account information using Singpass. To better manage your CPF savings, keep up with the latest news by having your contact details updated and subscribe to our email notifications.

Your page is loading.
One moment please.

13 Sep 2021
SOURCE: CPF Board


With increasing cancer prevalence and the emergence of higher-cost cancer drug therapies, the MediShield Life Council set up a Cancer Drug Committee to review coverage for outpatient cancer drug treatments to support Singaporeans’ continued access to good and affordable care.

 

From September 2022, MediShield Life will:

 

(i)      cover a list of clinically proven and cost-effective cancer drug treatments;

(ii)    set more granular claim limits ranging from $200 to $9,600 per month to provide more targeted coverage based on the cost of each cancer drug treatment; and

(iii)   allow patients to claim an additional limit of up to $1,200 per year from MediShield Life for cancer drug services, which include scans, blood tests and doctor consultations.

 

Once the changes take effect, close to 90% of subsidised patients in Singapore who use clinically proven and cost-effective treatments will have their cancer drug bills fully covered by subsidy and MediShield Life, subject to 10% co-insurance that can be paid using MediSave. In comparison, under today’s system, 70% of all subsidised Singaporean patients on cancer drug treatments have their bills fully covered.

 

MediSave withdrawal limits for outpatient cancer drug treatments and scans will also be adjusted together with the changes for MediShield Life.


Current and revised MediShield Life and MediSave limits

 

 

Current

Revised

MediShield Life

$3,000 per month for all cancer drug treatments and services

 

Ranges from $200 to $9,600 per month for cancer drug treatments on the positive list.

 

Additional $1,200 per year for cancer drug services.

MediSave

 

$1,200 per month for all cancer drug treatment sand services.

 

Additional $600 per year for cancer scans^.

$1,200 per month for cancer drug treatments with MediShield Life claim limit above $5,400, and $600 per month for other treatments on the positive list.

 

Additional $600 per year for cancer drug services and/or other cancer scans^.

^ MediSave can also be used for scans for post-treatment monitoring and radiotherapy patients

 

Source : MOH website


The positive list of cancer drug treatments that are claimable under MediShield Life and MediSave can be found on MOH’s website. It will be updated every four months to keep up with medical advancements.

 

At the same time, more cancer drugs will be added to the Standard Drug List and Medication Assistance Fund (MAF), and subsidised patients in public healthcare institutions will be eligible to receive up to 75% subsidy.

 

MAF subsidies will also be extended to more Singaporeans to improve affordability. This will apply to both cancer and non-cancer drugs listed on MAF.

Monthly Per Capita Household Income (PCHI)

MAF Subsidy Tier (Singapore Citizens)

Current

Revised

$0 ≤ PCHI ≤ $2,000

75%

$2,000 < PCHI ≤ $2,800

50%

$2,800 < PCHI ≤ $3,300

 

0%

50%

$3,300 < PCHI ≤ $6,500

40%

Source : MOH website


Below are some scenarios using actual bills to illustrate how the changes will result in improved affordability:

Source : MOH website



These changes are aimed at improving the affordability of cancer drug treatments as well as the sustainability of MediShield Life premiums in the long run.


Information accurate as of 13/9/2021